Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOTUS: Omega-3-acid Ethyl Esters in Hyperlipidemia
NCT02839902Phase 4Completed
- Sponsor
- Takeda
- Start
- Dec 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omega-3-acid triglycerides in hyperlipidemia, sponsored by Takeda. Started Dec 2016; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT02839902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02839902.